are currently using a GLP-1 agonist, including 45% of patients with Type 2 diabetes [22]
Stored at 2 to 8 degrees Celsius and away from light, a reconstituted vial is generally considered stable for up to 28 days by peptide compounding pharmacies, though no published peer-reviewed stability kinetics exist for BPC-157 specifically
Food and Drug Administration (FDA): FDA Statement on Compounded Semaglutide NovoCare (Novo Nordisk Patient Support): Wegovy Savings & Support NovoCare (Novo Nordisk Patient Support): Ozempic Savings Card & Support Novo Nordisk: Patient Assistance Program (PAP) The Journal of the American Medical Association (JAMA): FDA Issues Warnings About Compounded Versions of Semaglutide and Tirzepatide U.S
2021 Dec;177:247-259 PMID: 34737144 Quality Control & MSDS View current batch:
Key Research Benefits & Clinical Data Unrivaled Weight Reduction: Phase 2 clinical data published in the New England Journal of Medicine highlighted up to 24.2% body weight reduction over 48 weeks, outperforming dual agonists
Cleeks own weight struggles during childhood and adolescence led him to become credentialed in obesity medicine